A new study by experts at the University of Nottingham reviewed existing literature on the relationship between the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a class of diabetes medication—and alcohol consumption. The researchers explored whether GLP-1 RAs could potentially be used as a treatment to help people reduce their alcohol intake.
Diabetes medication shows promise in reducing alcohol consumption
A potential treatment option in the future for excessive alcohol use.
- Advertisement -
Explore more ..
High-fat diets and memory loss- A reversible story
Machine learning identifies early depression signals in facial patterns.
Why alcohol halts liver regeneration, even after quitting
New research links inflammation to faulty RNA processing
Breakthrough stool test could replace invasive colonoscopies
An artificial intelligence-based approach to diagnose colorectal cancer from the gut microbiota.
TRENDING
- Advertisement -